Table 1. Baseline characteristics of STEMI patients before and during the Covid-19 pandemics.
| Baseline characteristic | Total N = 841 | Covid-19 era, N = 424 | Control period, N = 417 | P value |
|---|---|---|---|---|
| Age, years median (IQR) | 62 (54,71) | 62 (55,71) | 61 (54,70) | .497 |
| Female gender, N (%) | 151 (18) | 81 (19) | 70 (17) | .432 |
| Diabetes Mellitus, N (%) | 287 (34) | 132 (31) | 155 (37) | .072 |
| Hypertension, N (%) | 460 (55) | 220 (52) | 240 (58) | .097 |
| Dyslipidemia, N (%) | 529 (63) | 246 (58) | 283 (68) | .003 |
| Current smoker, N (%) | 422 (50) | 206 (49) | 216 (52) | .388 |
| Prior CKD, N (%) | 60 (7.1) | 23 (5.4) | 37 (8.9) | .071 |
| Prior MI, N (%) | 188 (22) | 77 (18) | 111 (27) | .004 |
| Prior CABG, N (%) | 28 (3.3) | 11 (2.6) | 17 (4.1) | .314 |
| Prior PAD, N (%) | 36 (4.3) | 12 (2.8) | 24 (5.8) | .052 |
| Prior CHF, N (%) | 45 (5.4) | 18 (4.2) | 27 (6.5) | .199 |
| Prior stroke/TIA, N (%) | 69 (8.2) | 25 (5.9) | 44 (10.6) | .019 |
STEMI = ST-segment elevation myocardial infarction; IQR = Interquartile range; CKD = Chronic kidney disease; MI = Myocardial infarction; CABG = Coronary artery bypass grafting; PAD = peripheral artery disease; CHF = Congestive heart failure; TIA = transient ischemic attack.